Home » Pfizer CEO Expects Normalcy by 2022
Pfizer CEO Expects Normalcy by 2022
By Tom Wisely on 6月 17, 2021
As per the trusted sources of information, Pfizer CEO, Albert Bourla stated in an interview that he is looking forward to life returning to normal majorly in the developed countries by the end of 2021.
He further mentioned that life for other countries is likely to resume back to normal by the end of 2022.
He further added that by the end of next year, there would be enough vaccine doses for most nations worldwide to vaccinate their entire population successfully.
Pfizer and BioNTech have made one billion vaccines of COVID-19 in the previous week and are looking forward to manufacturing 3 billion doses by the end of this year.
The Pfizer Covid vaccine approved in the US has helped fight the infections. As a result, Infections have significantly declined in the US, besides falling hospitalization ratio and fatality.
Following this, the US authority has significantly eased out restrictions. Mask wearing mandates are no longer as stringent as before. Travel restrictions are also becoming more lenient. These developments suggest quick resumption to normalcy, similar to pre-Covid times.
The countries have been requesting the US to donate the leftover shots of the vaccines.
Pfizer promised to provide around 2 billion vaccine doses to the low and middle-income countries across the globe.
Bourla added that his company has a contract with around 120 countries for providing vaccines.
However, currently, most of the shots have been given to the developed countries as they placed the order before.
Published in Health and News
Pfizer Covid vaccine
US vaccination
Tom Wisely
Tom Wisely is a senior content writer at The Market Weekly and in a span of five years in writing, he has covered all of the vital development in pharma industry, device launch, pipeline drugs, commercial collaborations and the like
More from HealthMore posts in Health »